A 2025 pilot study showed intravenous BPC-157 was tolerated without side effects but did not measure efficacy in tendon healing
Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products
Some patients may experience symptoms that superficially resemble POTSsuch as dizziness, palpitations, or lightheadednesswhich are actually related to volume depletion, medication side effects, or rapid weight loss rather than true autonomic dysfunction
Having evolved to use GSH for this purpose, our cells have an entire array of enzyme systems designed to work with GSH for this purpose
Tamed my appetite
Both the thigh and the stomach are effective sites for injecting Ozempic (semaglutide)
